Reliable Biopharmaceutical Corporation Our company manufactures high quality active, and inactive pharmaceutical ingredients. Its proven ability to quickly deliver, affords its marketing partners the competitive advantage of being first to market, as well as the assurance of a product they can count on. Over the last four decades, the company has: Developed sophisticated API R&D and manufacturing capabilities, Built strong customer relationships with both generic and branded pharmaceutical and biotech companies, Developed and successfully commercialized 9 generic injectable drugs with its marketing partners, Maintained positive relations with the FDA, RBC also works on innovative drugs when its expertise and capabilities can be uniquely leveraged. We are well positioned to develop and manufacture APIs for increasingly complex drug molecules that will lose patent protection over the next 15 years. Our ability to develop and manufacture particularly complex generic APIs in both injectable and oral-solid dose, along with our FDA track record in compliant cGMP manufacturing, makes us the partner of choice for time critical and scientifically challenging projects. Our company differentiates itself by focusing on complex molecules within generic drugs, covering the range from complex synthetic and bio-derived to peptide based APIs. It provides our customers with compliance, speed, strong development capability, quality and exclusivity.